Key facts
- Tucuvi’s last known valuation is $14.3M (Sep 2024).
- It has raised $25.2M; the latest was Later Stage VC ($20.0M) in Jan 2026.
- Notable investors include European Innovation Council, Cathay Innovation, Cathay Capital, KFund, Frontline Ventures — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Tucuvi
- ·The full record, as it builds
Funding rounds
No funding rounds for Tucuvi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tucuvi
Developer of a healthcare platform designed to offer personalized care. The company's tool uses artificial intelligence and voice technology to offer medication reminders, treatment guidelines, cognitive stimulation exercises, symptoms of heart failure and other pathologies, caregiver satisfaction evaluation, and detection of basic needs, enabling healthcare professionals to scale their capacity of care and monitoring of their patients.
- Sector
- Healthcare
- HQ
- Madrid, Spain
- Founded
- 2019
- Employees
- 47
- Website
- tucuvi.com/
- Ownership
- Privately Held (backing)
Tucuvi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tucuvi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tucuvi in its N-PORT filings yet. We sweep new filings monthly.